Related Experiment Video
Updated: Jun 26, 2025
Using an α-Bungarotoxin Binding Site Tag to Study GABA A Receptor Membrane Localization and Trafficking
Published on: March 28, 2014
Shedding light on GPIbα shedding
Caitlin Debaene1,2, Hendrik B Feys1,2, Katrijn R Six1
1Transfusion Research Center, Belgian Red Cross Flanders.
Purpose Of Review:
Ectodomain shedding has been investigated since the late 1980s. The abundant and platelet specific GPIbα receptor is cleaved by ADAM17 resulting in the release of its ectodomain called glycocalicin. This review will address the role of glycocalicin as an end-stage marker of platelet turnover and storage lesion and will consider a potential function as effector in processes beyond hemostasis.
Recent Findings:
Glycocalicin has been described as a marker for platelet senescence, turnover and storage lesion but is not routinely used in a clinical setting because its diagnostic value is nondiscriminatory. Inhibition of glycocalicin shedding improves posttransfusion recovery but little is known (yet) about potential hemostatic improvements. In physiological settings, GPIbα shedding is restricted to the intracellular GPIbα receptor subpopulation suggesting a role for shedding or glycocalicin beyond hemostasis.
Summary:
So far, all evidence represents glycocalicin as an end-stage biomarker of platelet senescence and a potential trigger for platelet clearance. The extensive list of interaction partners of GPIbα in fields beyond hemostasis opens new possibilities to investigate specific effector functions of glycocalicin.
Insights
Glycocalicin, a marker of platelet turnover, is not clinically used due to non-specific diagnostic value. However, it may have roles beyond hemostasis and platelet clearance.
Area of Science:
- Biochemistry
- Hematology
- Cell Biology
Background:
- Ectodomain shedding of platelet receptors has been studied since the late 1980s.
- The GPIbα receptor, abundant and specific to platelets, is cleaved by ADAM17, releasing its ectodomain, glycocalicin.
Purpose of the Study:
- To review glycocalicin's role as an end-stage marker of platelet turnover and storage lesion.
- To explore glycocalicin's potential functions beyond hemostasis.
Main Methods:
- Literature review of studies on ectodomain shedding, GPIbα, ADAM17, and glycocalicin.
- Analysis of glycocalicin's diagnostic value and potential clinical applications.
- Investigation of physiological shedding patterns and implications.
Main Results:
- Glycocalicin is a marker for platelet senescence, turnover, and storage lesion but lacks discriminatory diagnostic value.
- Inhibiting glycocalicin shedding improves post-transfusion recovery, though hemostatic benefits are not fully understood.
- Physiological GPIbα shedding in intracellular subpopulations suggests roles beyond hemostasis.
Conclusions:
- Glycocalicin serves as an end-stage biomarker for platelet senescence and clearance.
- Further research into GPIbα interactions may reveal specific effector functions of glycocalicin in non-hemostatic processes.
Related Concept Videos
01:12GPCR Desensitization
01:22Activation and Inactivation of G Proteins